Spago Nanomedical focuses on the development of novel nanomedical tumor selective products for cancer diagnostics and therapy.
We welcome a dialogue with potential partners regarding cooperation and out-licensing of the company’s projects and technologies.
For more information regarding business development, please contact CEO Mats Hansen at mats.hansen@spagonanomedical.se